Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting

References

• Scott SA, Scott ER, Seki Y, et al. Development and analytical validation of a 29 gene clinical pharmacogenetic genotyping panel: multi-ethnic allele and copy number variant detection. Clin Transl Sci. 2020. doi:10.1111/cts.12844
   Web of Science ®Google Scholar
• Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95(4):423–431. doi:10.1038/clpt.2013.229
   PubMed Web of Science ®Google Scholar
• Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526(7573):343–350. doi:10.1038/nature15817
   PubMed Web of Science ®Google Scholar
• Williams MS. Early lessons from the implementation of genomic medicine programs. Annu Rev Genomics Hum Genet. 2019;20(1):389–411. doi:10.1146/annurev-genom-083118-014924
   Web of Science ®Google Scholar
• Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258–267. doi:10.1038/gim.2012.157
   PubMed Web of Science ®Google Scholar
• Weitzel KW, Elsey AR, Langaee TY, et al. Clinical pharmacogenetics implementation: approaches, successes, and challenges. Am J Med Genet C. 2014;166(1):56–67. doi:10.1002/ajmg.c.31390
   Web of Science ®Google Scholar
• Dunnenberger HM, Biszewski M, Bell GC, et al. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am J Health Syst Pharm. 2016;73(23):1956–1966. doi:10.2146/ajhp160072
   PubMed Web of Science ®Google Scholar
• O’donnell PH, Bush A, Spitz J, et al. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther. 2012;92(4):446–449. doi:10.1038/clpt.2012.117
   PubMed Web of Science ®Google Scholar
• Dunnenberger HM, Crews KR, Hoffman JM, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol. 2015;55(1):89–106. doi:10.1146/annurev-pharmtox-010814-124835
   PubMed Web of Science ®Google Scholar
• Van Der Wouden CH, Bank PCD, Özokcu K, Swen JJ, Guchelaar HJ. Pharmacist-initiated pre-emptive pharmacogenetic panel testing with clinical decision support in primary care: record of pgx results and real-world impact. Genes (Basel). 2019;10(6):416. doi:10.3390/genes10060416
   Web of Science ®Google Scholar
• Swen JJ, Van Der Straaten T, Wessels JA, et al. Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19. Eur J Clin Pharmacol. 2012;68(4):363–370. doi:10.1007/s00228-011-1130-4
   Web of Science ®Google Scholar
• Arwood MJ, Dietrich EA, Duong BQ, et al. Design and early implementation successes and challenges of a pharmacogenetics consult clinic. J Clin Med. 2020;9(7):2274. doi:10.3390/jcm9072274
   Web of Science ®Google Scholar
• Liko I, Corbin L, Tobin E, Aquilante CL, Lee YM. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program. Am J Health Syst Pharm. 2021;78(12):1094–1103. doi:10.1093/ajhp/zxab137
   Web of Science ®Google Scholar
• Brown JT, Gregornik D, Kennedy MJ. The role of the pediatric pharmacist in precision medicine and clinical pharmacogenomics for children. J Pediatr Pharmacol Ther. 2018;23(6):499–501. doi:10.5863/1551-6776-23.6.499
   Google Scholar
• Caraballo PJ, Hodge LS, Bielinski SJ, et al. Multidisciplinary model to implement pharmacogenomics at the point of care. Genet Med. 2017;19(4):421–429. doi:10.1038/gim.2016.120
   PubMed Web of Science ®Google Scholar
• Wang YT, Merl MY, Yang J, Zhu ZX, Li GH. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice. Pharmacogenomics J. 2020;20(2):169–178. doi:10.1038/s41397-019-0119-8
   Web of Science ®Google Scholar
• Roederer M, Van Riper M, Valgus J, Knafl G, Mcleod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Per Med. 2012;9(1):19–27. doi:10.2217/pme.11.87
   Web of Science ®Google Scholar
• Bank PC, Swen JJ, Guchelaar HJ. A nationwide survey of pharmacists’ perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. Pharmacogenomics. 2017;18(3):215–225. doi:10.2217/pgs-2016-0138
   Web of Science ®Google Scholar
• Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists. J Am Pharm Assoc (2003). 2014;54(5):510–517. doi:10.1331/JAPhA.2014.13041
   Web of Science ®Google Scholar
• Accreditation Council for Pharmacy Education. Accreditation standards and guidelines: professional program in pharmacy leading to the doctor of pharmacy degree; 2016. Available from: https://www.acpe-accredit.org/pdf/Standards2016FINAL.pdf. Accessed June 28, 2021.
   Google Scholar
• Roederer MW, Kuo GM, Kisor DF, et al. Pharmacogenomics competencies in pharmacy practice: a blueprint for change. J Am Pharm Assoc (2003). 2017;57(1):120–125. doi:10.1016/j.japh.2016.08.014
   Web of Science ®Google Scholar
• Haga SB, Moaddeb J. Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics. 2019;20(9):625–630. doi:10.2217/pgs-2019-0024
   PubMed Web of Science ®Google Scholar
• Cavallari LH, Overholser BR, Anderson D, et al. Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy. Pharmacotherapy. 2010;30(6):626. doi:10.1592/phco.30.6.626
   Web of Science ®Google Scholar
• Formea CM, Nicholson WT, Vitek CR, et al. Implementation of a pharmacogenomics education program for pharmacists. Am J Health Syst Pharm. 2018;75(23):1939–1946. doi:10.2146/ajhp170771
   PubMed Web of Science ®Google Scholar
• Marcinak R, Paris M, Kinney SRM. Pharmacogenomics education improves pharmacy student perceptions of their abilities and roles in its use. Am J Pharm Educ. 2018;82(9):6424. doi:10.5688/ajpe6424
   Web of Science ®Google Scholar
• Crown N, Sproule BA, Luke MJ, Piquette-Miller M, Mccarthy LM. A continuing professional development program for pharmacists implementing pharmacogenomics into practice. Pharmacy (Basel). 2020;8(2). doi:10.3390/pharmacy8020055
   Google Scholar
• Ferreri SP, Greco AJ, Michaels NM, et al. Implementation of a pharmacogenomics service in a community pharmacy. J Am Pharm Assoc. 2014;54(2):172–180. doi:10.1331/JAPhA.2014.13033
   Google Scholar
• O’connor SK, Ferreri SP, Michaels NM, et al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. Pharmacogenomics. 2012;13(8):955–962. doi:10.2217/pgs.12.67
   PubMed Web of Science ®Google Scholar
• Allen Lapointe NM. Challenges to integrating pharmacogenetic testing into medication therapy management. Pharmacogenomics. 2015;21(4):346–352.
   Google Scholar
• Gregory PA, Austin Z. How do patients develop trust in community pharmacists? Res Social Adm Pharm. 2021;17(5):911–920. doi:10.1016/j.sapharm.2020.07.023
   PubMed Web of Science ®Google Scholar
• Gregory PAM, Austin Z. Understanding the psychology of trust between patients and their community pharmacists. Can Pharm J. 2021;154(2):120–128. doi:10.1177/1715163521989760
   Web of Science ®Google Scholar
• Lopez T, Nuffer W. Impact and sustainability of a 10-year community pharmacy disease management service. Innov Pharm. 2021;12(1):13. doi:10.24926/iip.v12i1.3630
   Google Scholar
• Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc (2003). 2009;49(3):383–391. doi:10.1331/JAPhA.2009.09015
   PubMed Web of Science ®Google Scholar
• Brown JVE, Walton N, Meader N, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev. 2019;12(12):Cd013299. doi:10.1002/14651858.CD013299.pub2
   Web of Science ®Google Scholar
• Joseph T, Hale GM, Moreau C, Kourtakis SL, Wolowich WR. impact of a pharmacy-led transitions of care program within a primary care-based accountable care organization. Sr Care Pharm. 2021;36(6):311–316. doi:10.4140/TCP.n.2021.311
   Google Scholar
• Fazel MT, Bagalagel A, Lee JK, Martin JR, Slack MK. Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis. Ann Pharmacother. 2017;51(10):890–907. doi:10.1177/1060028017711454
   PubMed Web of Science ®Google Scholar
• Ramos H, Pardo J, Sánchez R, et al. Pharmacist-physician interprofessional collaboration to promote early detection of cognitive impairment: increasing diagnosis rate. Front Pharmacol. 2021;12:579489. doi:10.3389/fphar.2021.579489
   PubMed Web of Science ®Google Scholar
• Haga SB, Moaddeb J, Mills R, Voora D. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting. Pharmacogenomics. 2017;18(4):327–335. doi:10.2217/pgs-2016-0175
   Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–567. doi:10.1016/S0022-3999(99)00057-4
   PubMed Web of Science ®Google Scholar
• Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50(12):1013–1019. doi:10.1097/MLR.0b013e318269e121
   PubMed Web of Science ®Google Scholar
• Cella D, Hughes C, Peterman A, et al. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol. 2002;21(6):564–572. doi:10.1037/0278-6133.21.6.564
   PubMed Web of Science ®Google Scholar
• Haga SB. Evaluation of a pharmacogenetic educational toolkit for community pharmacists. Expert Rev Mol Diagn. 2016;17(14):1491–1502.
   Google Scholar
• Wallace LS, Rogers ES, Turner LW, Keenum AJ, Weiss BD. Suitability of written supplemental materials available on the Internet for nonprescription medications. Am J Health Syst Pharm. 2006;63(1):71–78. doi:10.2146/ajhp050071
   Web of Science ®Google Scholar
• Haga SB, Mills R, Moaddeb J, et al. Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics. 2016;17(15):1629–1636. doi:10.2217/pgs-2016-0077
   Web of Science ®Google Scholar
• Breaux S, Desrosiers FAD, Neira M, Sinha S, Nislow C. Pharmacogenomics at the point of care: a community pharmacy project in British Columbia. J Pers Med. 2020;11(1):11. doi:10.3390/jpm11010011
   Web of Science ®Google Scholar
• Haga SB, Moaddeb J, Mills R, et al. Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics. 2015;16(17):1931–1941. doi:10.2217/pgs.15.124
   PubMed Web of Science ®Google Scholar
• Bright D, Worley M, Porter BL. Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Social Adm Pharm. 2020;17(4):744–749. doi:10.1016/j.sapharm.2020.06.022
   Web of Science ®Google Scholar
• Mukherjee C, Sweet KM, Luzum JA, et al. Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort. Per Med. 2017;14(5):383–388. doi:10.2217/pme-2017-0022
   Web of Science ®Google Scholar
• Olson JE, Rohrer Vitek CR, Bell EJ, et al. Participant-perceived understanding and perspectives on pharmacogenomics: the mayo clinic RIGHT protocol (right drug, right dose, right time). Genet Med. 2017;19(7):819–825. doi:10.1038/gim.2016.192
   PubMed Web of Science ®Google Scholar
• Mills R, Haga SB. Qualitative user evaluation of a revised pharmacogenetic educational toolkit. Pharmgenomics Pers Med. 2018;11:139–146. doi:10.2147/PGPM.S169648
   Web of Science ®Google Scholar
• Truong TM, Lipschultz E, Danahey K, et al. Assessment of patient knowledge and perceptions of pharmacogenomics before and after using a mock results patient web portal. Clin Transl Sci. 2020;13(1):78–87. doi:10.1111/cts.12681
   Web of Science ®Google Scholar
• Asiedu GB, Finney Rutten LJ, Agunwamba A, et al. An assessment of patient perspectives on pharmacogenomics educational materials. Pharmacogenomics. 2020;21(5):347–358. doi:10.2217/pgs-2019-0175
   Web of Science ®Google Scholar
• Romagnoli KM, Boyce RD, Empey PE, Adams S, Hochheiser H. Bringing clinical pharmacogenomics information to pharmacists: a qualitative study of information needs and resource requirements. Int J Med Inform. 2016;86:54–61. doi:10.1016/j.ijmedinf.2015.11.015
   PubMed Web of Science ®Google Scholar
• Brown JT, Macdonald D, Yapel A, et al. Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinic. Pharmacogenomics. 2021;22(4):203–212. doi:10.2217/pgs-2020-0178
   Web of Science ®Google Scholar
• Charland SL, Agatep BC, Herrera V, et al. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the additional KIF6 risk offers better adherence to statins (AKROBATS) trial. Pharmacogenomics J. 2014;14(3):272–280. doi:10.1038/tpj.2013.27
   Web of Science ®Google Scholar
• Wang J, Ford LJ, Wingate L, et al. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. J Am Pharm Assoc (2003). 2013;53(1):46–53. doi:10.1331/JAPhA.2013.12019
   PubMed Web of Science ®Google Scholar
• Tucker R, Stewart D. Why people seek advice from community pharmacies about skin problems. Int J Pharm Pract. 2015;23(2):150–153. doi:10.1111/ijpp.12126
   Google Scholar